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Abstract
CEACAM1 is a multifunctional Ig-like cell adhesion molecule expressed by epithelial cells in many organs. CEACAM1-4L and
CEACAM1-4S, two isoforms produced by differential splicing, are predominant in rat liver. Previous work has shown that
downregulation of both isoforms occurs in rat hepatocellular carcinomas. Here, we have isolated an anchorage dependent
clone, designated 253T-NT that does not express detectable levels of CEACAM1. Stable transfection of 253-NT cells with a
wild type CEACAM1-4S expression vector induced an anchorage independent growth in vitro and a tumorigenic phenotype
in vivo. These phenotypes were used as quantifiable end points to examine the functionality of the CEACAM1-4S
transmembrane domain. Examination of the CEACAM1 transmembrane domain showed N-terminal GXXXG dimerization
sequences and C-terminal tyrosine residues shown in related studies to stabilize transmembrane domain helix-helix
interactions. To examine the effects of transmembrane domain mutations, 253-NT cells were transfected with
transmembrane domain mutants carrying glycine to leucine or tyrosine to valine substitutions. Results showed that
mutation of transmembrane tyrosine residues greatly enhanced growth in vitro and in vivo. Mutation of transmembrane
dimerization motifs, in contrast, significantly reduced anchorage independent growth and tumorigenicity. 253-NT cells
expressing CEACAM1-4S with both glycine to leucine and tyrosine to valine mutations displayed the growth-enhanced
phenotype of tyrosine mutants. The dramatic effect of transmembrane domain mutations constitutes strong evidence that
the transmembrane domain is an important determinant of CEACAM1-4S functionality and most likely by other proteins
with transmembrane domains containing dimerization sequences and/or C-terminal tyrosine residues.
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Introduction
CEACAM1 is a member of the carcinoembryonic antigen
(CEA) gene family of Ig-like cell-cell adhesion molecules [1,2].
Like other members of this family, CEACAM1 is a type I
transmembrane protein with a heavily glycosylated extracellular
region composed of four Ig-like domains, a transmembrane
domain and a cytoplasmic tail [3]. In the rat liver there are two
allelic variants of CEACAM1 which differ by 16 amino acids in
their N-terminal domains [2,4] and two major splice variants,
designated 4L and 4S, that are distinguished by differences in the
length of their cytoplasmic tails of 70–72 amino acids and 10–12
amino acids, respectively [2,4,5].
Both isoforms of CEACAM1 are down-regulated in epithelial
cancers arising in the liver, prostate, bladder and colon
[6,7,8,9,10,11,12], a finding that prompted re-expression analysis
aimed at defining structure and function relationships. Restoration
of expression by infecting rat cell lines derived from primary
hepatocellular carcinomas (r-HCC) with a CEACAM1-4L retro-
virus resulted in potent growth suppression in vitro and tumor
suppression in vivo [13]. Further analysis showed that the 4L
cytoplasmic domain was necessary and sufficient for tumor
suppression [14], an activity that required phosphorylation of
serine 503 and in colon carcinoma cells, concurrent phosphory-
lation of tyrosine 488 [15,16].
In contrast to CEACAM1-4L, CEACAM1-4S failed to generate
a tumor suppressor phenotype when re-expressed in r-HCC or
mouse colon carcinoma cell lines [13,17,18]. However when
expressed in MCF7 mouse mammary carcinoma cells, CEA-
CAM1-4S induced glandular morphogenesis, an activity requiring
phosphorylation at one or more sites in the 4S cytoplasmic domain
[19,20,21]. Site directed mutagenesis further showed that
mutation of phenylalanine 445 at the C-terminus of the
CEACAM1-4S cytoplasmic domain not only compromised
interactions with the actin cytoskeleton but also inhibited lumen
formation, suggesting interactions of CEACAM1-4S with the
cytoskeleton were an important determinant of glandular
morphogenesis. Interestingly, when mouse mammary carcinoma
cells were grown in humanized NOD/SCID mouse mammary fat
pads, only the 4L isoform initiated morphogenesis, the opposite of
what was observed in vitro [21], raising questions about the
equivalence of in vitro and in vivo models of morphogenesis.
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Ig domain [22,23,24], like the cytoplasmic domain, has been the
focus of numerous investigations. The adhesive epitope within the
N-terminal Ig-domain has been defined for rat [24], mouse and
human CEACAM1 [22,23], the evolutionary relationships
between CEACAM1 from different species has been determined
[25,26] and the three dimensional structure has been established
by X-ray crystallography [27]. In comparison, the CEACAM1
transmembrane domain has received relatively little attention,
perhaps because transmembrane domains have often been viewed
as passive anchor sequences that span the lipid bilayer. Over the
last 10 years, this simplistic viewpoint has fallen by the wayside in
the face of accumulating evidence implicating transmembrane
domains in helix-helix interactions leading to dimerization,
oligomerization and signal transduction [28,29,30]. The possible
involvement of transmembrane-transmembrane domain interac-
tions in the functionality of CEACAM1 was suggested by the
presence of repeating GXXXG motifs (where X represents any
amino acid), sequences known to control protein dimerization and
signaling [30,31], and the presence of transmembrane C-terminal
tyrosine residues shown in other proteins to be mediators of
molecular recognition, self assembly and signal transduction [32].
In the present investigation, we have examined the effect of
transmembrane domain mutations on the ability of CEACAM1-
4S to confer an anchorage independent phenotype when
expressed in a clonal line of CEACAM1 negative, anchorage
dependent rat hepatocellular carcinoma cells, designated 253-NT.
Our results show that transmembrane mutations in both GXXXG
and tyrosine residues have both positive and negative effects on the
anchorage independent phenotype produced by wild type
CEACAM1-4S.
Methods
Antibodies
The origin and characteristics of MAb 5.4 specific for
CEACAM1 and MAb 188.A2 specific for rat transferrin receptor
have been described previously [33,34]. Monoclonal antibody 9.2
(MAb 9.2) was provided by Drs. Werner Reutter and Oliver Baum
at the Free University, Berlin, Germany [35]. Mouse anti-human
HLA antibody was purchased from Sigma-Aldrich (Sigma-Aldrich
Co., St. Louis, MO). The preparation of polyclonal rabbit anti-
peptide antibodies specific for the CEACAM1-4L and CEA-
CAM1-4S has been previously described [36]. The secondary
antibodies used for indirect immunofluorescence labeling were
Alexa-488 conjugated goat anti-mouse and goat anti-mouse-HRP
conjugated secondary antibody (Invitrogen, Carlsbad, CA, USA).
Cell Culture
The parental cell line 253T was established from a 2-
acetylaminofluorene induced rat hepatocellular carcinoma, as
described previously [35]. The anchorage dependent 253T-NT
cell line was isolated from 253T by limiting dilution cloning. 253T
and 253-NT cells were grown in Waymouth medium (Sigma, St.
Louis, MO, USA) supplemented with 15% FBS, 1% glutamine
(Invitrogen), 0.1% Gentamycin (Invitrogen), and 0.2% Normocin
(Invivogen, San Diego, CA, USA). For cell proliferation assays,
1.5610
4 cells were plated in a 24-well plate. At 24, 48, 72, and
96 hours after plating, cells were trypsinized (Invitrogen), stained
with trypan blue and counted using a hemocytometer.
Construction of a CEACAM1-4S Expression Vector
RNA was isolated from a normal Fisher rat liver using RNAzol B
accordingtothemanufacturer’sinstructions(Tel-Test,Friendswood,
TX).cDNAwassynthesized fromthe purified RNAaccordingtothe
manufacturer’s instructions using the SuperScript III first-strand
synthesis system for RT-PCR (Invitrogen). CEACAM1-4S cDNA
was amplified by PCR from the total cDNA product using primers:
CEACAM1-4S Forward 59CAGGAATT-CATGGAGCTAGCC-
TCGGCT-39 and CEACAM1-4S Reverse 59-CGAGTCGACT-
CGTCAGAAGGAC CCAGATCC-39. The primers contained
EcoRI and SalI restriction sites.
Restriction Digest
A restriction digest was performed on both the CEACAM1-
4S PCR product and the pCl-neo plasmid (Promega, Madison,
WI, USA) using EcoRI and SalI (New England Biolabs, Ipswich,
MA, USA). Following digestion, the plasmid and the PCR
product were dephosphorylated using Antarctic phosphatase
(New England Biolabs), heat-treated to inactivate the phospha-
tase, and run on a 1% agarose gel. Bands corresponding to the
plasmid DNA and CEACAM1-4S PCR product were purified
using the Geneclean spin kit (Qbiogene, Morgan Irvine, CA,
USA). The CEACAM1-4S PCR product was ligated into the
pCI-neo plasmid using T4 DNA ligase (New England Biolabs).
Ligated plasmid was transformed into One Shot OmniMax 2
T1 Phage-Resistant Cells (Invitrogen) according to the manu-
facturer’s protocol. Transformed cells were plated onto LB/
CARB plates and resulting colonies were screened by PCR
using forward and reverse primers for CEACAM1-4S (see
above). Plasmid DNA from four CEACAM1-4S positive clones
was isolated using the Qiagen Endofree maxiprep kit (Valencia,
CA, USA) and submitted for DNA sequencing to the W.M.
Keck Biotechnology Laboratory at Yale University (New
Haven, CT).
Selection of Sites for Mutagenesis
Mutation sites were chosen based on the consensus location of
the transmembrane domain predicted by the different membrane
topology algorithms shown in Table 1. The results from this
analysis showed that the various transmembrane prediction
algorithms delineated transmembrane domains with variable N
(G424 to I431) and C (Y445 to S449) termini and different
numbers of potential GXXXG motifs. All of the predicted
transmembrane domains lacked the terminal GLSE predicted by
Kyte Doolittle and Hopp-Wood (Table 1) and thus did not include
the G420-LSE-G424 motif. Ten of the 12 predicted transmem-
brane domains included G428, strongly suggesting the presence of
the two motifs centered on G432 (G428-IVI-G432 and G432-
SVA-G436). Although G424 was present in only 3 of 12 predicted
TM, G424’s location at the N-terminus of a tandem array of three
classic GXXXG motifs caused us to consider that the G424-AIA-
G432 sequence might function as a dimerization motif when all
the other GXXXG motifs were disrupted by G428L and G436L
mutations. With regard to the C terminus, all of the predicted
transmembrane domains contained Y445 and 7 of 12 contained
Y448, leading us to conclude with reasonable certainty that Y448
was within the transmembrane domain or at the very least, at the
interface between the transmembrane and cytoplasmic domains.
Taking all of these considerations into account, we arrived at the
transmembrane sequence proposed in Table 2. The brackets
denote the uncertainty with regard to G424 and Y448. In
recognition of the variability in the predicted N-terminus and the
uncertainty regarding the functionality of the G424-AIA-G428
motif, we introduced a G424L mutation to disrupt this motif and a
G432L mutation to knock out both the G428-IVI-G432 and the
G432-SVA-G436 motifs. Disruption of all three of the possible
GXXXG motifs was accomplished by introducing both G424L
Transmembrane Growth Regulation
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Y445 and Y448 were replaced with V, the choice of a tyrosine to
valine mutation being based on the following considerations: 1)
valine lacks a hydroxy group; 2) valine does not have an aromatic
side chain; 3) valine is non-polar and thus should not disrupt the
alpha helix or alter transport to the plasma membrane.
Site-directed Mutagenesis
Site-directed mutagenesis was performed on the pCI-neo
plasmid containing the CEACAM1-4S gene using the Quik-
Change II XL Site-directed mutagenesis kit (Stratagene, La Jolla,
CA, USA) according to the manufacturer’s protocol. The
oligonucleotide primers used for mutagenesis were as follows:
Table 1. Survey of Servers.
Amino Acid Sequence: Source
GLSEGAIAGIVIGSVAGVALIAALAYFLY Wild type
424 432 445 448
GLSEGAIAGIVIGSVAGVALIAALAYFLY FASTA KYTE-DOOLITTLE
1
SGLSEGAIAGIVIGSVAGVALIAALAYFLYS ProtScale Hopp-Woods
2
GAIAGIVIGSVAGVALIAALAYF SOSUI
3
IAGIVIGSVAGVALIAALAYFLY TMHMM2.0
4
IAGIVIGSVAGVALIAALAYF PREDICT PROTEIN (PHDhtm)
5
AIAGIVIGSVAGVALIAALAYFLY PREDICT PROTEIN (solvent access)
6
AIAGIVIGSVAGVALIAALAYFL HMMTOP; DAS
7
IVIGSVAGVALIAALAYFLYS TMpred
8
IGSVAGVALIAALAYFLYSRKTG PALEALE
9
AIAGIVIGSVAGVALIAALAY OCTOPUS
10
IAGIVIGSVAGVALIAALAYFLY WESA
11
GIVIGSVAGVALIAALAYFL MEMSAT3
12
1http://fasta.bioch.virginia.edu/fasta_www2/fasta_www.cgi,
2http://web.expasy.org/cgi-bin/protscale/protscale.pl,
3http://bp.nuap.nagoya-u.ac.jp/sosui/sosui_submit.html,
4http://www.cbs.dtu.dk/services/TMHMM/,
5https://www.predictprotein.org/,
6http://www.enzim.hu/hmmtop/html/submit.html,
7http://www.sbc.su.se/,miklos/DAS/,
8http://www.ch.embnet.org/software/TMPRED_form.html,
9http://distill.ucd.ie/paleale/,
10http://octopus.cbr.su.se,
11http://pipe.scs.fsu.edu/wesa.html,
12http://bioinf.cs.ucl.ac.uk/psipred/.
doi:10.1371/journal.pone.0029606.t001
Table 2. CEACAM1-4s Transmembrane Domain.
Amino Acid Sequence:
Wild type GLSE[G]AIAGIVIGSVAGVALIAALAYFL[Y]
Residues of Interest 424 432 445 448
Mutants:
G424L GLSE[L]AIAGIVIGSVAGVALIAALAYFL[ Y]
G432L GLSE[ G]AIAGIVILSVAGVALIAALAYFL[ Y]
G424L/G432L GLSE[L]AIAGIVILSVAGVALIAALAYFL[ Y]
Y445V GLSE[ G]AIAGIVIGSVAGVALIAALAVFL[ Y]
Y448V GLSE[ G]AIAGIVIGSVAGVALIAALAYFL[V]
Y445V/Y448V GLSE[ G]AIAGIVIGSVAGVALIAALAVFL[V]
G424L/G432L/Y445V GLSE[L]AIAGIVILSVAGVALIAALAVFL[ Y]
G424L/G432L/Y448V GLSE[L]AIAGIVILSVAGVALIAALAYFL[V]
G424L/G432L/Y445V/Y448V GLSE[L]AIAGIVILSVAGVALIAALAVFL[V]
doi:10.1371/journal.pone.0029606.t002
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CAGGCATTGTG-39, G424L Reverse 59-CACAATGCCTG-
CAATGGCAAGCTCTGAGAGGCCAG-39, G4-31L Forward
59-GCAG-GCATTGTGATTCTATCTGTGGCTGGAGTGG-
CC-39, G432L Reverse 59-GGCCACTCCAGCCACA-GATA-
GAATCACAATGCCTGC-39, Y448V Forward 59-GCGCTG-
GCATACTTCCTTGTTTCCAGGA-AGACTGGC-39,Y 4 4 8 V
Reverse 59-GCCAGTCTTCCTGGAAACAAGGAAGTATGC-
CAGCGC-39, Y445V Forward 59-CCTAATAGCAGCGCTGG-
CAGTCTTCCTTTATTCCAGG-39, Y445V Reverse 59-CCTG-
GAATAAAGGAAGACTGCCAGCGCTGCTATTAGG-39.T o
create the Y445V and Y448V double mutant, a Y448V mutation
was introduced into the Y445V mutant using the following primer
set: Forward 59-GCGCTGGCAGTCTTCCTTGTTTCCAGGA-
AGACTGGC-39;R e v e r s e5 9-GCCAGTCTTC-CTGGAAACAA-
GGAAGACTGCCAGCGC-39.
Generation of Stably Transfected Sublines of 253T-NT
For transfection of 253-NT cells, 1610
6 cells at 75% confluence
were transfected with 7.5 mg of plasmid DNA in Lipofectamine
LTX reagent (Invitrogen) following the manufacturer’s recom-
mended protocol. After incubation for 24 hours in complete
medium, stable transfectants were selected by maintaining cells in
complete medium containing geneticin (Invitrogen) at 600 mg/ml
with medium changes every 48 hours. For all subsequent
experiments, geneticin resistant cells were maintained in complete
selection medium.
Indirect Immunofluorescence
Cells were seeded in permanox chamber slides (Nalge Nunc
International, Rochester, NY) at a density of 1610
5 cells/ml and
incubated in a 5% CO2 humidified chamber for 48–72 hours.
Cells were washed three times in ice-cold PBS and fixed for
10 min in ice-cold acetone. Normal liver sections and frozen
tumor sections were prepared as previously described [37]. Cells
were blocked for 15 min with 1% normal goat serum (Sigma-
Aldrich) in PBS and incubated for 30 min at room temperature
with a 1:200 dilution of primary MAb 9.2 specific for CEACAM1-
4S. After three washes in PBS, cultures were fixed with 4%
paraformaldehyde for 1 min, quenched in 0.1 M glycine in PBS,
and incubated at 4uC for 30 min in Alexa 488 conjugated goat
anti-mouse IgG (1:400 dilution). Cells were examined by
fluorescence microscopy using a Nikon Eclipse E800 microscope
(Nikon Instruments, Inc., Melville, NY).
Confocal Microscopy
Confocal images were acquired with a Nikon PCM 2000 (Nikon
Inc. Mellville, NY, USA) using the Argon (488) and the green
Helium-Neon (543) lasers. Serial optical sectioning was performed
with Simple 32, C-imaging computer software (Compix Inc,
Cranberry Township, PA, USA). Z series sections were collected
at 0.5 mm using a 606PlanApo objective and a scan zoom of 26.
Images were processed in NIH Image J (National Institutes of
Health, Springfield, VA, USA).
FACS Analysis
Cells were harvested at 75% confluence using non-enzymatic
cell dissociation solution (Sigma-Aldrich) and labeled in suspen-
sion with anti-CEACAM1-4S monoclonal antibody MAb 9.2 as
described above. Primary and secondary antibodies were diluted
in 1% normal goat serum in PBS and incubated sequentially
with cells at 4uC for 20 min. Cells were washed with sterile ice
cold sort buffer (Ca/Mg++ free, pH 7.0 PBS, 5 mM EDTA,
2 mM HEPES and 1% FBS) and resuspended at a final
concentration of 8–10610
6 cells/ml. CEACAM1-4S positive
cells were isolated by FACS as previously described by Comegys
et al. [38].
Anchorage Independent Growth
Cells were harvested using non-enzymatic cell dissociation
solution (Sigma-Aldrich), suspended in 0.76% low melting point
agar diluted 1:1 with 26 complete Waymouth medium (Sigma-
Aldrich) and seeded in 6 well plates (10
4 cells/well) coated with
2 mls of 1.25% low melting point agar (Sigma-Aldrich) diluted
1:1 with 26complete Waymouth medium. Plates were incubated
at 37uC for three weeks and analyzed microscopically to identify
anchorage independent clones. Colony size was determined from
digital micrographs using Image-Pro Plus 5.0 software (Media
Cybernetics, Inc., Bethesda, MD) to determine the average area
calculated from measurements made on a total of 15–30
colonies.
Tumorigenicity in Nude Mice
All animal studies were performed using protocols approved by
the Rhode Island Hospital Institutional Animal Care and Use
Committee (cmtt# 0268-98). Athymic nude mice were purchased
from Harlan (Indianapolis, IN). Twenty-four hours prior to
transplantation of tumor cells, animals were injected intraperito-
neally with anti-LY2.2 antibodies containing anti-asialo GM1 to
suppress T-cell and NK cytotoxic activity, respectively [39,40].
Cultured cells were harvested as described previously [13].
Subcutaneous injections with 5610
6 cells per site were performed
under aseptic conditions into both of the upper flanks. For
intraperitoneal injections, mice were injected with 2610
6 cells
suspended in HBSS. Tumors were excised at three weeks post-
injection, weighed, frozen in a hexane/acetone bath and stored at
280uC. Tumors were analyzed by indirect immunofluorescence
as described above.
Immunoblot Analysis Following Blue-Native (BN) PAGE
BN-PAGE analysis was performed on crude membrane isolates
prepared from 253T-NT cells stably transfected with empty
vector, wild type CEACAM1-4S and each of the single and
double glycine mutants described above. Cell pellets were thawed
on ice and lysed following 10 passages through a 20-gauge
needle. Lysates were centrifuged at 3,500 rpm for 15 min at 4uC
and MgCl2 and benzonase (Sigma Aldrich) were added to the
supernatant to give final concentrations of 2 mM and 1 unit/ml,
respectively. After incubation at room temperature for 30 min,
membranes were centrifuged at 17,000 rpm for 15 min at 4uC.
Blue-native (BN) PAGE electrophoresis was performed using the
Native Page Novex Bis-Tris gel system (Invitrogen). Membrane
pellets were solubilized on ice for 30 min in 16 Native Page
sample buffer (Invitrogen) containing 1% dodecyl-ß-D-maltoside
(Invitrogen) and protease inhibitors. After a 30 min incubation,
the samples were centrifuged at 20,0006gf o r2 0m i na t4 uCt o
remove insoluble material. A Bradford assay (Bio-Rad, Hercules,
CA, USA) was performed to determine protein concentration.
One ml of 5% NativePage G-250 sample additive (Invitrogen)
was added to each sample, and the samples and a Native Mark
protein ladder (Invitrogen) were loaded into the wells of a 4–16%
Bis-Tris gel (Invitrogen). After running at 150 V for approxi-
mately 30 min, the cathode buffer was changed from 0.02% to
0.002% G-250 and electrophoresis at 150 V was continued for an
additional 120 min. BN-PAGE gels were immunoblotted onto
PVDF membranes (Bio-Rad). Transfer was performed using Bio-
Rad’s semi-dry transfer apparatus for 1 hour at 25 V. After
Transmembrane Growth Regulation
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15 min, rinsed with water and air-dried. PVDF membranes were
re-hydrated with methanol, rinsed with water and blocked in 5%
milk overnight at 4uC. Blots were labeled with antibodies as
previously described [24].
Immunoblot Analysis Following SDS-PAGE
Immunoblots were prepared with extracts from 80% confluent
cell cultures lysed in RIPA buffer (Pierce, Rockford, IL, USA)
containing protease and phosphates inhibitors (Calbiochem). Cell
lysates were centrifuged at 14,000 rpm for 15 min and resolved by
SDS-PAGE. Immunoblots were prepared and visualized as
previously described, using MAb 9.2 to detect CEACAM1-4S
[13]. The density of the MAb 9.2 reactive bands was determined
by image analysis of digital images of immunoblots captured using
a Versadoc Imaging System (Bio-Rad) and Quantity One software
(Bio-Rad), as previously described [13].
Statistical Analysis
A paired t-test was performed to determine statistical signifi-
cance using GraphPad QuickCalcs software (GraphPad Software
Inc., La Jolla, CA).
Results
Expression of CEACAM1-4S by 253-NT Cells Restores the
Anchorage Independent Phenotype Exhibited by the
Parental 253T Cell Line
In previous investigations, we focused on the structural and
functional determinants of tumor suppression mediated by
CEACAM1-4L, one of two major splice variants expressed in
rat liver [13,16]. The primary goal in these studies was to gain
insight into the role of the cytoplasmic and extracellular domains
in cell adhesion and tumor suppression. In the present report, we
have focused on the CEACAM1 transmembrane domain, a
relatively uncharacterized region shared by both the 4L and 4S
isoforms. Our cell model for these studies was an anchorage
dependent, CEACAM1 negative subclone designated 253-NT
that was derived clonally from the parental rat 253T cell line [6].
When suspended in soft agar, 253T cells continued to grow and by
three weeks had formed well-defined anchorage independent
colonies (Figure 1A). In comparison, soft agar cultures of 253-NT
cells showed no evidence of significant growth and after three
weeks were composed almost entirely of single cells (Figure 1B). In
contrast, 253-NT cells stably transfected with a wild type
CEACAM1-4S expression plasmid and enriched by FACS to
Figure 1. Anchorage Independent Growth Induced by Expression of CEACAM1-4S. (A) A representative anchorage independent colony
formed by parental 253T cells after 3 weeks in soft agar. (B) Sparsely scattered single cells that typified soft agar cultures of 253T-NT cells. (C)
Scattered cells remaining after 3 weeks in soft agar cultures of 253T-NT cells stably transfected with empty vector. (D) A representative colony formed
by253T-NT cells stably transfected with a wild type CEACAM1-4S expression vector.
doi:10.1371/journal.pone.0029606.g001
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regained the anchorage independent phenotype of the parental
253T cells (Figure 1C) while cells stably transfected with empty
vector (Figure 1D) had not grown significantly after 3 weeks in soft
agar.
Wild Type and Transmembrane Domain Mutants were
Expressed at Similar Levels on the Surface of Stably
Transfected 253T-NT Cells
Sequence analysis showed that the CEACAM1-4S transmem-
brane domain contained multiple GXXXG dimerization motifs
and two C-terminal tyrosine residues which in other transmem-
brane receptors were involved in transmembrane domain
dependent signaling events [30,31,32]. To determine if these
transmembrane domain elements played a part in the anchorage
independent phenotype induced by CEACAM1-4S, nine expres-
sion vectors encoding CEACAM1-4S with transmembrane
domain mutations in the GXXXG motifs and/or tyrosine residues
were constructed as described under Methods and shown in
Table 1. These vectors were used to produce stably transfected
sublines of 253-NT. Single G424L or G432L mutations or double
G424L/G432L mutations were introduced to disrupt two or more
GXXXG motifs. Substituting leucine for glycine introduced a
large hydrophobic amino acid that maintained the hydrophobic
character of the transmembrane domain but disrupted the
conformation of the transmembrane domain helix [28]. Trans-
membrane domain tyrosine residues were mutated to valine, a
substitution that replaced tyrosine with a non-polar hydrophobic
amino acid lacking a hydroxyl group in its side chain. In other
systems, proper spacing of the tyrosine hydroxyl group had been
shown to be necessary for signaling events dependent upon
protein-protein interactions [41].
Examination by confocal fluorescence microscopy of cultures
established from CEACAM1-4S positive cells isolated by FACS
showed intense membrane fluorescence when labeled by indirect
immunofluorescence with CEACAM1 specific MAb 9.2, confirm-
ing that both wild type and mutant forms of CEACAM1-4S were
properly transported to the plasma membrane (Figure 2, A–L).
Empty vector transfected and untransfected 253-NT cells showed
no detectable reactivity with MAb 9.2 (Figure 2, E and J,
respectively). Immunoblot analysis indicated that the wild type and
mutant proteins all had an apparent molecular mass of 105 kDa,
the expected size for CEACAM1-4S isoform [2], suggesting that
post-translational processing has not been altered (Figure 3).
Quantitative analysis by flow cytometry of FACS selected, stably
transfected cells labeled by IIF with MAb 9.2 indicated that 72–
83% of the cells were positive for either wild type or mutated forms
of CEACAM1-4S (Figure 4).
Soft Agar Colonies of 253T-NT Cells Expressing Y to V
Mutants Increased in Size at a Much Faster Rate Than
Colonies Composed of Cells Transfected with WT-
CEACAM1-4S or G to L Mutants
The effect of transmembrane domain mutations on anchorage
independent growth was determined from changes in the average
areas of soft agar colonies (Figure 5 and 6). When 253T-NT cells
expressing wild type (Figure 1C), single or double tyrosine mutants
of CEACAM1-4S were grown in soft agar, sublines expressing
tyrosine mutants (Figure 5 D, E, F and Figure 6) showed a 3.5-fold
increase in colony size relative to cells transfected with the wild
type protein (Figure 1C and Figure 6). In contrast, 253T-NT cells
expressing CEACAM1-4S with GXXXG motifs disrupted by G to
L mutations (Figure 5A, B, C and Figure 6) either did not grow or
formed colonies that for the double glycine mutant (Figure 5C and
6), were less than half the size of those formed by cells expressing
the wild type protein (Figure 1C and Figure 6). Moreover, the
rapid growth phenotype conferred by tyrosine to valine mutants
appeared to be dominant over the growth suppressed phenotype
displayed by glycine to leucine mutants since all of the sublines
with both glycine to leucine and tyrosine to valine mutations
displayed enhanced anchorage independent growth (Figure 5G,
H, I and Figure 6).
The Size of Soft Agar Colonies Formed by 253T-NT Cells
Expressing Wild Type and Mutant Forms of CEACAM1-4S
was Closely Correlated with the Rate of Proliferation
Proliferation assays were carried out to ascertain whether the
size of soft agar colonies (Figure 5 and 6) was proportional to the
rate of proliferation in vitro calculated from changes in cell number
as a function of time. As shown in Figure 7, 253T-NT cells
expressing wild type CEACAM1-4S proliferated 2.2 times faster
than 253T-NT cells carrying the empty vector and from 1.4-2.2
times faster than cells transfected with glycine mutants. Consistent
with their rapid growth in soft agar, 253T-NT cells expressing
CEACAM1-4S with single or double tyrosine mutants proliferated
at rates that were 1.4–1.6-fold higher than cells with wild type
CEACAM1-4S. Taken together, these data suggested that the
CEACAM1-4S transmembrane domain was controlling interac-
tions involved in growth under anchorage independent conditions,
interactions that were altered by GXXXG or tyrosine mutations.
Transmembrane Mutations Change the Ability of Wild
Type CEACAM1-4S to Promote a Tumorigenic Phenotype
in Nude Mice
To determine if changes in anchorage independent growth
induced by transmembrane domain mutations were mirrored by
altered tumorigenicity, nude mice were injected subcutaneously in
the upper flanks with 253T-NT cell lines expressing wild type or
mutant CEACAM1-4S. Subcutaneous tumors were harvested
from animals at three weeks after injection, a time point chosen by
necessity because of the large tumor burden in animals injected
with 253T-NT cells expressing tyrosine mutants. On average,
tumors produced by cells expressing wild type CEACAM1-4S
were 5.5- and 6.5-fold larger by weight than those generated by
cells transfected, respectively, with the empty vector or the single
G424L mutant (Figure 8). While cells expressing the wild type
protein formed tumors comparable in weight to those formed by
cells expressing the double G to L mutant, 253T-NT cells
expressing CEACAM1-4S with single Y448V, double Y445V/
Y448V or quadruple G424L/G432L/Y445V/Y448V mutations
produced tumors that were 1.9-, 1.25-, and 2.14-fold larger than
those produced by cells transfected with the wild type protein
(Figure 8). Indirect immunofluorescence analysis of frozen tumor
sections, confirmed that tumor nodules formed by 253-NT cells
transfected with either wild type or transmembrane domain
mutants remained strongly positive for CEACAM1-4S (Figure 9).
Disruption of GXXXG Motifs by Double G to L Mutations
Caused an Increase in the Mobility of Wild Type
CEACAM1-4S Detected in Western Blots Prepared from
Blue Native Gels
Previous reports have demonstrated that dimerization via
transmembrane domain helix-helix interactions are often mediated
by GXXXG or GXXXA motifs within the transmembrane domain
[30,42]. To determine if the GXXXG motifs within the transmem-
brane domain of CEACAM1-4S played a role in the dimerization of
Transmembrane Growth Regulation
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CEACAM1-4S interactions was analyzed by Blue-Native polyacryl-
amide gel electrophoresis (BN-PAGE). In BN-PAGE, Coomassie
G-250 is used in place of SDS to coat proteins with a uniform
negative charge without causing denaturation or disruption of
protein-protein interactions [44]. As shown in Figure 10, wild
type and single G-to-L mutants of CEACAM1 demonstrated an
apparent molecular mass by BN-PAGE that was approximately
100 kDa higher than the double G to L mutant, a difference
approximately the size of CEACAM1-4S resolved by reducing
SDS-PAGE. These data suggested that a single GXXXG motif
was sufficient to mediate dimerization of CEACAM1-4S and/or
interaction with another yet-to-be identified transmembrane
protein, interactions that appeared to require helix-helix
interactions mediated by GXXXG motifs.
Discussion
The ability of CEACAM1-4S expression in the context of the
proteome of 253-NT cells to restore the tumorigenic and anchorage
Figure 2. Cell Surface Expression of CEACAM1-4S. 253T-NT cultures stably transfected with wild type or mutated forms of CEACAM1-4S were
labeled by indirect immunofluorescence with MAb 9.2, a monoclonal antibody specific for CEACAM1. Cell nuclei were stained with propidium iodide.
Confocal digital images constructed from 7–15 optical sections for each labeled subline are shown in panels A–L. (A) wild type CEACAM1-4S; (B)
G424L mutant; (C) G432L mutant; (D) G424L and G432L double mutant; (E) Empty vector; (F) Y445V mutant; (G) Y448V mutant; (H) Y445V and Y448V
double mutant; (I) G424L, G432L, Y445V, Y448V quadruple mutant; (J) untransfected 253T-NT cells; (K) G424L, G432L and Y445V triple mutant; (L)
G424L, G432L and Y448V triple mutant. Scale bar represents 20 mm.
doi:10.1371/journal.pone.0029606.g002
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provided a quantifiable, reproducible endpoint for examining the
functionality of the CEACAM1-4S transmembrane domain. The
idea that CEACAM1 phenotypes could be context specific came
from our previous studies showing that CEACAM1-4L expression
dramatically suppressed the tumorigenicity of CEACAM1 negative
PC-3humanprostatecarcinomacells[13].Withcontinued passage,
however, cells eventually reacquired a tumorigenic phenotype
without losing expression of CEACAM1-4L, suggesting a strong
selection for cells with proteomes that were unable to support
CEACAM1 mediated tumor suppression. Context dependent
effects on CEACAM1-4S phenotypes were also suggested by the
ability of CEACAM1-4S to induce morphogenesis of MCF7 cells in
vitro but not in vivo [21].
Analysis of the amino acid sequence of the CEACAM1-4S
transmembrane domain revealed the presence of four GXXXG
sequences (Table 1 and 2), a motif known to drive high affinity
helix-helix interactions that stabilize the dimerization/oligomeri-
zation of many well characterized proteins such as glycophorin A,
epidermal growth factor receptor and the G protein-coupled a-
factor receptor of budding yeast [30,42,45]. For the latter protein,
disruption of the GXXXG motif not only impaired oligomeriza-
tion but also disrupted signaling [30,46]. Previous investigations
have shown that both the long and short isoforms of CEACAM1
form cis-dimers [36,43], an interaction that we hypothesized
should be stabilized by GXXXG mediated helix-helix associations.
To test this idea, we introduced glycine-to-leucine mutations that
disrupted one or more transmembrane domain GXXXG motifs.
FACS, fluorescent confocal microscopic and immunoblot analysis
of cells stably transfected with the glycine-to-leucine mutants
confirmed that the mutant proteins were expressed on the cell
surface at the same level and the same size as wild type
CEACAM1-4S. However, after 3 weeks in soft agar, cells
expressing single glycine mutants showed significantly lower rates
of proliferation and significantly smaller colonies when compared
to cells transfected with wild type CEACAM1-4S, suggesting that
a single glycine-to-leucine mutation had compromised the ability
of CEACAM1-4S to induce anchorage independent growth. From
these results, we concluded that the smaller size of colonies
produced by glycine mutants resulted at least in part from a
decrease in the rate of proliferation.
Since the double glycine mutation disrupted all of the GXXXG
motifs, a corresponding decrease in either homo- or hetero- cis-
dimerization would be expected if these motifs were the sole
mediators of this interaction. However, impaired dimerization
could also occur if a reduction in GXXXG motifs destabilized cis-
dimers formed by single glycine mutants with a subsequent
reduction in their steady state levels. Blue native-PAGE analysis
showed that the apparent size of the double but not the single
glycine mutants showed approximately a 100 kDA decrease in
size, a shift consistent with impaired dimerization. Moreover, since
single glycine to leucine mutations produced the growth
suppressed phenotype but only double mutations hampered
dimerization, it was concluded that even without an apparent
effect on dimerization, glycine to leucine point mutations in the
transmembrane domain had a profound effect on the growth
phenotype produced by CEACAM1-4S.
With one exception, the effects of transmembrane domain
mutations on growth in vivo were similar to those observed in vitro.
In keeping with their limited capacity for anchorage independent
growth, cells transfected with empty vector were poorly tumori-
genic relative to cells expressing the wild type CEACAM1-4S. As
predicted from their growth in soft agar, cells expressing the
G424L mutant formed tumors considerably smaller than those
derived from cells expressing wild type CEACAM1-4S. However,
the similarity in the size of tumors generated by cells expressing the
wild type, double glycine and double tyrosine mutants was at odds
with in vitro assays where cells expressing wild type CEACAM1-4S
showed a significantly greater or lesser capacity, respectively, for
anchorage independent growth than cells expressing double
glycine or tyrosine mutants. This discrepancy is reminiscent of
the differential in glandular morphogenesis exhibited in vitro and in
vivo by MCF7 mammary carcinoma cells [21] and thus could
reflect differential effects of the subcutaneous microenvironment.
In general, tumors formed by cells expressing the single and
double tyrosine mutants were much larger than those generated by
cells transfected with wild type CEACAM1-4S or empty vector, a
trend consistent with the greater rate of proliferation shown in vitro
by tyrosine mutants. When viewed as a whole, these findings show
that the phenotypes manifested in vitro by cells expressing
transmembrane domain mutants are recapitulated in vivo,
suggesting these changes are intrinsic to the transmembrane
domain and are not the result of extrinsic factors e.g.,
microenvironment, that change the phenotypic effects of CEA-
CAM1-4S by altering its proteomic context.
The decrease in soft agar growth produced by glycine mutations
and the increase by tyrosine mutations relative to the wild type
CEACAM1-4S would classify these, respectively, as loss-of-function
and gain-of-function mutations [47,48,49]. Gain-of-function muta-
tions are usually dominant, a characteristic apparent for the
glycine/tyrosine mutants of CEACAM1-4S where the growth
enhanced phenotype of tyrosine mutants was dominant over the
growth inhibitedphenotype resulting from glycine mutations. Based
on the known functions of GXXXG motifs, it seems likely that the
loss-of-function caused by glycine mutations is related to changes in
helix-helix interactions that destabilize rather than prevent the
formation of cis-dimers [28,50,51], a possibility consistent with the
fact that single G424L or G432L mutations failed to disrupt
dimerization (Figure 10) but did cause a decrease in anchorage
independent growth. Also noteworthy is the marked decrease in cis-
dimerization (Figure 10) when mutations were introduced at both
G424 and G432, a result that suggested G424-AIA-G428 was a
Figure 3. Immunoblot Analysis Shows that Wild Type and
Mutant CEACAM1-4S Constructs Have Identical Molecular
Mass. Protein lysates prepared from wild type cells and each of the
253T-NT transfected cell lines were resolved on 7.5% SDS-polyacyla-
mide gels, transferred onto nitrocellulose and labeled with MAb 9.2
specific to CEACAM1. Analysis of expressed wild type and mutant
CEACAM1-4S protein shows that reactive band corresponding to
CEACAM1-4S had the same apparent molecular mass (105 kDa).
doi:10.1371/journal.pone.0029606.g003
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PLoS ONE | www.plosone.org 8 January 2012 | Volume 7 | Issue 1 | e29606Figure 4. FACS Analysis of CEACAM1-4S Expression in Transfected and Untransfected 253T-NT Sublines. FACS analysis was performed
to determine the percentage of CEACAM1-4S positive cells in the various sublines. When 253T-NT cells were labeled with a human HLA specific
monoclonal antibody (negative control), only 5% of the cells showed fluorescence above background levels (A). When stained with MAb 188-A2
specific for transferrin receptor (positive control), 95% of the cells showed positive reactivity (B). (C–M) the percentage of positive cells is indicated in
the upper left corner of each histogram. Sublines analyzed in each panel were transfected with: (C) wild type CEACAM1-4S; (D) empty vector; (E)
G424L; (F) G432L; (G) G424L and G432L; (H) Y445V; (I) Y448V; (J) Y445V and Y448V; (K) G424L, G432L and Y445V; (L) G424L, G432L and Y448V; (M)
G424L, G432L, Y445V and Y448V.
doi:10.1371/journal.pone.0029606.g004
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PLoS ONE | www.plosone.org 9 January 2012 | Volume 7 | Issue 1 | e29606Figure 5. Anchorage Independent Growth in Soft Agar. (A–I) show the appearance of colonies formed by the various CEACAM1-4S sublines
after 3 weeks in soft agar: (A) G424L; (B) G432L; (C) G424L and G432L; (D) Y445V; (E) Y448V; (F) Y445V and Y448V; (G) G424L, G432L and Y445V; (H)
G424L, G432L and Y448V; (I) G424L, G432L, Y445V and Y448V.
doi:10.1371/journal.pone.0029606.g005
Figure 6. Size Distribution of Soft Agar Colonies. Image ProPlus software was used to calculate the average area of soft agar colonies. The
results represent three separate soft agar growth experiments. The columns marked with an asterisk indicate sublines that were either significantly
smaller or larger than those formed by cells transfected with wild type (WT) CEACAM1-4S (p,0.05).
doi:10.1371/journal.pone.0029606.g006
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the absence of the two motifs centered on G432 and necessary to
sustain the level of growth produced by wild type CEACAM1-4S.
Although this conclusion is seemingly at odds with the 9 prediction
algorithms that placed G424 outside the transmembrane domain
(Table 1),we suggest that a combinationofstructuraland functional
data provides a more accurate location of the transmembrane
domain, one that incorporates the GAIAG motif at the N-terminus.
Similar reasoning can be applied to the C-terminus where 5 of
12 transmembrane prediction algorithms placed Y448 outside the
transmembrane domain. However, mutation of either Y445 or
Y448 led to the soft agar growth enhanced phenotype, indicating
first, that Y448 was functionally equivalent to Y445 and thus likely
to be located within the transmembrane domain and second, that
both tyrosines were required to sustain anchorage independent
growth at the level produced by wild type CEACAM1-4S.
Figure 7. Rates of Cell Proliferation of CEACAM1-4S Transfectants. The bars show the fold-increase in cells at 96 hours after plating. The
columns marked with an asterisk were sublines showing an increase in cell number between 0 and 96 hours that according to P values (p,0.05), was
significantly higher or lower than 253T-NT cells transfected with wild type (WT) CEACAM1-4S. In general, the number of 253T-NT cells expressing G to
L mutants increased at a slower rate and Y to V mutants at a higher rate than cells expressing wild type CEACAM1-4S. Results shown represent four
separate assays.
doi:10.1371/journal.pone.0029606.g007
Figure 8. Tumorigenicity of 253T-NT Transfected with WT and Mutated CEACAM1-4S. Three nude mice were injected in the front flanks
with each subline of 253T-NT (6 injection sites for each cell line). At three weeks after injection, tumor nodules were harvested and weighed. Columns
marked with an asterisk indicate cell lines that according to P values (p,0.05) were significantly larger (Y448V and the quadruple mutant) or smaller
(G424L) than 253T-NT cells expressing wild type CEACAM1-4S. Although the effects of mutations were not as clear-cut as those observed for growth
in soft agar, the G424L mutation compromised and the Y448V or the quadruple mutation enhanced the ability of CEACAM1-4S to produce tumors in
nude mice.
doi:10.1371/journal.pone.0029606.g008
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was moot since single Y445V or Y448V mutations produced the
growth-enhanced phenotype in soft agar. Put another way, the
presence of both tyrosines appeared to be necessary to suppress
anchorage independent growth, a suppressive effect that appar-
ently involved more than interactions between aromatic side
chains since in both single tyrosine to valine mutants (VFLY or
YFLV) the remaining tyrosine was paired with F446. Whether the
two tyrosines without phenylalanine would be able maintain the
wild type CEACAM1-4S phenotype is an open question that is
beyond the scope of the present investigation.
While the mechanism behind the gain-of-function produced by
the Y mutations is less clear, there is increasing evidence
supporting the functional importance of interactions between
transmembrane aromatic amino acids [41]. Although aromatic
residues make up only a small percentage of the amino acids in
any given protein, they are generally the most highly conserved
residues. Interactions between the aromatic rings of phenylalanine,
tryptophan (W) or tyrosine are thought to involve pi-stacking, a
process that creates an attractive force when aromatic rings
assume energetically favored stacking geometries. Accumulating
evidence suggests that pi-stacking plays an important role in
molecular recognition and self assembly either by contributing
energy for driving self assembly or by providing directionality and
orientation through stacking geometries [52,53]. When a bacterial
transmembrane database was statistically analyzed by Sal-Man et
al, these investigators found that aromatic pairs (WXXW or
YXXY) were significantly over-represented compared to their
predicted frequency, suggesting a functional role for these
sequences [52]. The stabilization of transmembrane domain self-
association following substitution of tyrosine for glutamine (Q) and
serine (S) in the known dimerization motif, QXXS, provided
support for this idea and led these authors to conclude that
stabilization of transmembrane associations by aromatic residues
may be a general mechanism for generating specificity in
transmembrane-transmembrane interactions. In considering
which amino acid to substitute for the transmembrane tyrosine
residues, phenylalanine would intuitively seem to be the logical
Figure 9. Expression of WT and Mutant CEACAM1-4S on Tumor Nodules. Frozen sections of normal liver or 253T-NT transfectants were
stained by indirect immunofluorescence with MAbs 9.2 and 5.4, monoclonal antibodies recognizing the N-terminal Ig domain of CEACAM1-4S. (A)
Normal rat liver with MAb 5.4; (B) 253T-NT expressing wild type CEACAM1-4S; (C–F) tumors of 253-NT cells expressing the following mutants: (C)
G424L with MAb 9.2; (D) G424L and G432L with MAb 5.4; (E) Y448V with MAb 5.4; (F) Y445V and Y448V with MAb 9.2.
doi:10.1371/journal.pone.0029606.g009
Figure 10. Mobility of G to L Mutants of CEACAM1-4S Resolved
by BN-PAGE. Protein lysates were prepared and resolved by BN-PAGE
as described under materials and methods. Proteins were transferred
onto PVDF membranes and probed with monoclonal antibody 9.2.
When separated on native gels, wild type CEACAM1-4S and the single G
mutants migrated with an apparent molecular mass that was
approximately 100 kDa higher than the double glycine mutant.
doi:10.1371/journal.pone.0029606.g010
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anine mutations may or may not disrupt function. Stevens et al
[54] reported that a YS/FA mutation of the IgM transmembrane
domain had no effect on anti-Ig induced signaling as measured by
the activation of tyrosine phosphorylation and did not disrupt the
association between IgM and its signaling partners, Ig-alpha/Ig-
beta. In contrast, a YS/VV mutation diminished both signaling
and association with Ig-alpha/Ig-beta. In cases where phenylal-
anine substitutions fail to mimic tyrosine, the lack of a properly
spaced hydroxy group may be the reason [41]. Based on these
considerations, it was decided to introduce tyrosine to valine
mutations.
GXXXG motifs and aromatic amino acids are common
features of the transmembrane domains of many different plasma
membrane proteins with GXXXG motifs most often located at the
N-terminus [55,56,57] and Y/F/W aromatic amino acids at the
C-terminus of the transmembrane domain [58,59]. Many of the
proteins also have Sternberg-Gullick dimerization motifs, a family
of sequences discovered in the transmembrane domain of tyrosine
kinase growth factor receptors [60]. Members of this family, which
includes a subset of GXXXG/AXXXG/SXXXG dimerization
motifs, are composed of 5 amino acids arranged with G, A, S, T or
P in the first position (N-terminus), an A, V, L or I in the fourth
position and G or A in the fifth position. Our findings demonstrate
that a single amino acid substitution in the transmembrane
domain of CEACAM1-4S can produce dramatic effects on cell
proliferation, anchorage independent growth and in vivo tumori-
genicity. It seems clear that the transmembrane domain and more
specifically GXXXG motifs and tyrosine residues make a
significant contribution to the functionality of CEACAM1-4S
and by extension, to other transmembrane proteins with similar
characteristics. Further studies are needed to define the down-
stream signaling events impacted by re-expression of CEACAM1-
4S or by transmembrane domain mutations, studies that should
provide valuable insights into events controlled by transmembrane
domain mediated interactions. Of particular interest will be the
identity of pathways inactivated/activated by tyrosine mutations
that lead to the positive growth effects of tyrosine mutations and
the ability of these pathways to counteract the tumor suppressor
activity of CEACAM1-4L, the larger splice variant with the same
transmembrane domain as the 4S isoform.
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